AI & ChatGPT searches , social queriess for CUREVAC
Search references for CUREVAC. Phrases containing CUREVAC
See searches and references containing CUREVAC!
Search references for CUREVAC. Phrases containing CUREVAC
See searches and references containing CUREVAC!CUREVAC
German bio-pharmaceutical company
CureVac is a biopharmaceutical company based in Tübingen, Germany that develops therapies based on messenger RNA (mRNA). With approximately 375 employees
CureVac
Vaccine candidate against COVID-19
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness
CureVac_COVID-19_vaccine
German state-owned investment and development bank
corporations, including Deutsche Post, Deutsche Telekom, Commerzbank, and CureVac. In 2013, KfW agreed to help establish a Portuguese financial institution
KfW
Swiss-American biotechnology company
additional companies such as Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others. CRISPR Therapeutics has drugs approved and in development
CRISPR_Therapeutics
German biotechnology company
advanced stages of clinical development. In June 2025, BioNTech acquired CureVac, a German biopharmaceutical firm and a former rival in the COVID-19 vaccine
BioNTech
German biologist and businessman
concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly
Ingmar_Hoerr
Vaccine against SARS-CoV-2
the Pfizer–BioNTech and Moderna vaccines. The CVnCoV mRNA vaccine from CureVac failed in clinical trials. Severe allergic reactions to the mRNA vaccines
COVID-19_vaccine
British pharmaceutical and biotechnology company
(€955 million). In July 2020, GSK acquired a 10% stake in German biotech company CureVac. In March 2018, GSK announced that it has reached an agreement with Novartis
GSK_plc
Scenic mountain road loop in Montenegro
route include: the villages of Mala Crna Gora, Trsa, and Pišče; peaks like Ćurevac, Prutaš and Savin Kuk; mountains including Crvena Greda and Sedlena Greda;
Durmitor_Ring
American biotechnology company
patent infringement over their mRNA-based COVID-19 vaccine. DNA vaccine CureVac "2025 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission
Moderna
Public-private organization for vaccine development
Retrieved February 3, 2020. "CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". CureVac AG. January 31, 2020. Archived
Coalition for Epidemic Preparedness Innovations
Coalition_for_Epidemic_Preparedness_Innovations
)public CSPC (1992- )public CSPC Zhongrun (1989– ) Curaxys (bef 2025- ) CureVac (2000– )public Cyclacel (1997– )public Cynapsus (subsidiary of Sunovion;
List of pharmaceutical companies
List_of_pharmaceutical_companies
Canyon in Montenegro and Bosnia and Herzegovina
is best visible at Bailovica Sige waterfalls. Further is the bottom of Curevac mountain that reaches 1,650 metres (5,410 ft). In 2005 and 2009, the European
Tara_River_Canyon
Public research university in Tübingen, Germany
by extension to the COVID-19 vaccine programs by BioNTech, Moderna and CureVac. The university played a leading role in efforts to legitimize the policies
University_of_Tübingen
Aspect of viral disease pandemic
Janssen J&J 11 March 2021 April 2021 Novavax 20 December 2021 Pending Valneva Pending Pending Sanofi–GSK Pending Pending CureVac Request withdrawn No
COVID-19_pandemic_in_Denmark
Plan to immunize against COVID-19
Moderna, AstraZeneca, and Janssen. Iceland has also signed a contract with CureVac. Iceland signed a contract on December 9, 2020, with Pfizer, and a contract
COVID-19 vaccination in Iceland
COVID-19_vaccination_in_Iceland
Canadian biotechnology company
into a development and option agreement with German biotechnology company CureVac to jointly develop a product incorporating Acuitas' LNP technology with
Acuitas_Therapeutics
Scientific work to develop a vaccine for COVID-19
and a rolling review of CVnCoV, a COVID‑19 vaccine being developed by CureVac AG. In February 2021, the EMA announced that they are developing vaccine
History of COVID-19 vaccine development
History_of_COVID-19_vaccine_development
Sovereign wealth fund of Qatar
October 2025. Sovereign (21 July 2020). "CureVac Raises a Total of USD 640 Million in Private Financing Round". CureVac. Retrieved 21 October 2025. "Califia
Qatar_Investment_Authority
Placeholder infectious disease name from the World Health Organization
February 2019, CEPI announced funding of US$34 million to the German-based CureVac biopharmaceutical company to develop an "RNA Printer prototype", that CEPI
Disease_X
Plan to immunize against COVID-19
Janssen 11 March 2021 23 April 2021 Novavax 20 December 2021 Not yet Valneva Pending Not yet Sanofi–GSK Pending Not yet CureVac Request withdrawn No
COVID-19 vaccination in France
COVID-19_vaccination_in_France
Speciality chemicals Leverkusen 2015 Materials and coatings, part of Bayer P A CureVac Health care Biotechnology Tübingen 2000 Vaccine P A Daimler Truck Industrials
List_of_companies_of_Germany
Distribution and administration of COVID-19 vaccinations
vaccine €8.43 US$10.00 Sinopharm Sinopharm BIBP vaccine €8.43 US$10.00 CureVac CureVac vaccine €10.00 Pfizer and BioNTech Pfizer–BioNTech vaccine €12.00 Moderna
Deployment of COVID-19 vaccines
Deployment_of_COVID-19_vaccines
Plan to immunize against COVID-19
Netherlands/Israel 900 000 11 March 2021 Pending Novavax US 20 December 2021 Pending CureVac Germany Pending Pending Valneva France Pending Pending Sanofi–GSK France/UK
COVID-19 vaccination in Croatia
COVID-19_vaccination_in_Croatia
Plan to immunize against COVID-19
million doses of the AstraZeneca/Oxford vaccine, 35 million doses of the CureVac vaccine, 22 million doses of the Johnson & Johnson vaccine, 39 million
COVID-19 vaccination in Mexico
COVID-19_vaccination_in_Mexico
Plan to immunize against COVID-19
Vaccine Type (technology) Phase I Phase II Phase III CureVac RNA Completed Completed In progress ReiThera Viral vector Completed Completed In progress
COVID-19 vaccination in Argentina
COVID-19_vaccination_in_Argentina
Medical technology
still face major delivery hurdles. BioNTech, Moderna Therapeutics and CureVac focus on delivery of mRNA payloads, which are necessarily non-viral delivery
Gene_therapy
Dutch politician and scientist (born 1957)
(UMCG). Plasterk's company was acquired by German biopharmaceutical company CureVac in July 2022 for €32 million, half of which was conditional on future results
Ronald_Plasterk
Plan to immunize against COVID-19
EU-gemensamt avtal om covid-19-vaccin med CureVac" [Sweden joins the collective EU COVID-19 vaccine contract with CureVac] (Press release) (in Swedish). Ministry
COVID-19 vaccination in Sweden
COVID-19_vaccination_in_Sweden
Promotion agency of the European Union
of Wise Ingmar Hoerr, founder and chairman of the supervisory board of CureVac Fredrik Hörstedt, Director at Vinnova Talis Juhna, Professor and vice-rector
European_Innovation_Council
German physician (born 1961)
Singer Dieter Thomas Kuhn, Lisa Federle and CureVac-Founder Ingmar Hoerr
Lisa_Federle
GX-19 Inovio Inactivated KD-414 NDV-HXP-S RNA ARCT-021 ARCT-154 Bangavax CureVac (terminated) HGC019 mRNA-1283 PTX-COVID19-B Sanofi–Translate Bio (terminated)
COVID-19_pandemic_in_Nepal
Chemically modified messenger RNA
(BNT162b2), and by Moderna (mRNA-1273). The zorecimeran vaccine developed by Curevac, however, uses unmodified mRNA, instead relying on codon optimization to
Nucleoside-modified messenger RNA
Nucleoside-modified_messenger_RNA
Immunisation against COVID-19
GSK/Sanofi Pasteur UK/France phase III clinical trials 60 million Pending Pending CureVac Germany phase III clinical trials 50 million Pending Pending
COVID-19 vaccination in the United Kingdom
COVID-19_vaccination_in_the_United_Kingdom
River in Montenegro, Bosnia and Herzegovina
100 metres (3,600 ft) high. Further is the bottom of the mountain top, "Curevac" (1,650 metres; 5,410 ft), that rises above Tara as its "eternal guardian"
Tara_(Drina)
Vaccination campaign against the COVID-19 pandemic in Romania
1,826,313 11 March 2021 4 May 2021 Novavax US 20 December 2021 Pending CureVac Germany Pending Pending Valneva France Pending Pending Sanofi/GSK France/UK
COVID-19 vaccination in Romania
COVID-19_vaccination_in_Romania
Belgian businessman
OncoDNA. Since September 2015 he was a member of the supervisory board of CureVac, a German biopharmaceutical company specialising in mRNA-based drugs. In
Jean_Stéphenne
Canadian researcher
mRNA COVID-19 vaccines that Acuitas developed with Pfizer/BioNTech and CureVac. The Pfizer/BioNTech COVID-19 mRNA vaccine BNT162b2 relies on an LNP delivery
Pieter_Cullis
Immunization plan against COVID-19 in Italy
Janssen 11 March 2021 21 April 2021 Novavax 20 December 2021 Pending Valneva Pending Pending Sanofi–GSK Pending Pending CureVac Request withdrawn No
COVID-19_vaccination_in_Italy
Clinical research to establish the characteristics of COVID-19 vaccines
vaccines: Oxford–AstraZeneca, Pfizer–BioNTech, Moderna, Novavax, VLA2001, CureVac, and Janssen. On 16 December, WHO recommendations on heterologous vaccinations
COVID-19 vaccine clinical research
COVID-19_vaccine_clinical_research
immunotherapy company Frame Therapeutics (Amsterdam, 2018) since 2022 part of CureVac. Löwenberg's research activities at Erasmus University Medical Center Rotterdam
Bob_Löwenberg
"Company – Immatics". immatics.com. Retrieved 10 December 2017. "curevac.de: Company". Curevac.com. Retrieved 10 December 2017. "SYNIMMUNE GmbH: Welcome".
Hans-Georg_Rammensee
G20 COVID-19 global initiative
AstraZeneca/University of Oxford (AZD1222), Clover Biopharmaceuticals (SCB-2019), CureVac (Zorecimeran/CVnCoV), Inovio (INO-4800), Institut Pasteur (MV-SARS-CoV-2)
Access to COVID-19 Tools Accelerator
Access_to_COVID-19_Tools_Accelerator
Basketball team in Sarajevo, Bosnia and Herzegovina
and Dontay Caruthers with 15, alongside notable contributions from Haris Ćurevac and team captain Muhamed Pašalić. The title marked the club’s first national
KK_Bosna_Royal
Sequence of major events in a virus pandemic
million times since its launch on 16 June. On the same day, German company CureVac announced that it was ready to begin clinical trials of a potential coronavirus
Responses to the COVID-19 pandemic in June 2020
Responses_to_the_COVID-19_pandemic_in_June_2020
German chemist
Hoerr and Florian von der Mülbe founded the biopharmaceutical company CureVac AG. In his pioneering PhD thesis Ingmar Hoerr was the first to develop
Günther_Jung
Canyon : Limestone rock crevices near the Sokolina (Plužine Municipality) and Ćurevac peaks (Žabljak Municipality) Edraianthus pilosulus (Beck) Surina & Lakušić
List of endemic species of Montenegro
List_of_endemic_species_of_Montenegro
Plan to immunize against COVID-19
Oxford–AstraZeneca Viral vector Completed Completed Completed Janssen Viral vector Completed Completed In progress CureVac RNA Completed Completed In progress
COVID-19_vaccination_in_Peru
Practice of researchers trying procedures on themselves
Rammensee, professor of immunology at University of Tübingen and co-founder of CureVac began testing a COVID-19 vaccine on himself. In May 2020, Alexander Gintsburg
Self-experimentation in medicine
Self-experimentation_in_medicine
Austrian physician
percent protective' - DW - 16.02.2017". DW.COM. Dolgin, Elie (2021-06-18). "CureVac COVID vaccine let-down spotlights mRNA design challenges". Nature. 594
Peter_Gottfried_Kremsner
Plan to immunize against COVID-19
but recognition on 31 March 2022 Sputnik V Pending (but suspended since March 2022) No but recognition on 31 March 2022 CureVac Request withdrawn No
COVID-19 vaccination in Germany
COVID-19_vaccination_in_Germany
Moderna, AstraZeneca, Janssen. Iceland has also signed a contract with CureVac. On 21 November 2021, it was reported that 90% of the Icelandic population
COVID-19_pandemic_in_Iceland
Plan to immunize against COVID-19
European portfolio - Moderna, Pfizer-BioNTech, Oxford–AstraZeneca, Sanofi, CureVac, Novavax, and Janssen, even though it had some reservations regarding its
COVID-19 vaccination in Bulgaria
COVID-19_vaccination_in_Bulgaria
Immunization plan against COVID-19 in Spain
Pending Pending Valneva Pending Pending Pending Pending Sanofi–GSK Pending Pending Pending Pending CureVac Request withdrawn Request withdrawn No No
COVID-19_vaccination_in_Spain
Immunization plan against COVID-19 in Portugal
February 2021 Janssen 11 March 2021 Yes Novavax 20 December 2021 Pending Valneva Pending Pending Sanofi–GSK Pending Pending CureVac Request withdrawn No
COVID-19 vaccination in Portugal
COVID-19_vaccination_in_Portugal
Plan to immunize against COVID-19
Yes Yes Moderna Yes Yes Janssen Yes Yes Sputnik V Yes Yes Convidecia Yes No Novavax Yes No Sanofi–GSK Pending No CureVac Pending No Valneva Pending No
COVID-19 vaccination in Hungary
COVID-19_vaccination_in_Hungary
COVID-19 immunization campaign
February 2021 Janssen 11 March 2021 5 May 2021 Novavax 20 December 2021 Pending CureVac Pending Pending Valneva Pending Pending Sanofi–GSK Pending Pending
COVID-19 vaccination in Norway
COVID-19_vaccination_in_Norway
Plan to immunize against COVID-19
Vaccine Type (technology) Phase I Phase II Phase III Clover Subunit Completed Completed Completed CureVac RNA Completed Completed In progress
COVID-19 vaccination in Colombia
COVID-19_vaccination_in_Colombia
CUREVAC
CUREVAC
CUREVAC
CUREVAC
Girl/Female
Anglo Saxon
A Tungrian goddess.
Girl/Female
Hindu
Shore, Musical instrument, Goddess of wealth
Boy/Male
Muslim
Authority, King
Surname or Lastname
English
English : probably from the possessive case of the Middle English word eam ‘uncle’, denoting a retainer in the household of the uncle of some important local person.English : possibly also a variant of Ames.
Boy/Male
Tamil
Boy/Male
Hindu, Indian, Traditional
Lord Ganesh
Boy/Male
Hindu
Sun, Vishnu
Girl/Female
English
Abbreviation of Elizabeth and Eliza.
Male
Croatian
, precious.
Girl/Female
Australian, British, Christian, Danish, English, Finnish, French, German, Greek, Latin, Swedish
A Diminutive of Priscilla Made Famous by 1960s British Singer Cilia Black; Fruitful; Blind; Ancient; Sixth
CUREVAC
CUREVAC
CUREVAC
CUREVAC
CUREVAC